2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3271
  



  

  
Submitter : 
  

  
Mrs. Sandra Reso
  

  
Date & Time: 
  

  
12/14/2006 01:12:25
  



  

  
Organization : 
  

  
Mrs. Sandra Reso
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
I am opposed to the use of aborted fetal cell line products in any type of vacinnes manufactured by the pharmacutecal companies.